ConductScience.org, home

Paper39626907

Cryoablation for Malignant Bone and Soft Tissue Tumors and Histological Assessment of Ablated Tumors.

Asanuma K and 8 others. Anticancer Res, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Cryoablation for Malignant Bone and Soft Tissue Tumors and Histological Assessment of Ablated Tumors. Papers, record 39626907. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39626907

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cryoablation for Malignant Bone and Soft Tissue Tumors and Histological Assessment of Ablated Tumors.
PubMed
Journal
Anticancer Res
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.84, provisional
iCite
Revised in PubMed
2024-12-03
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Asanuma KKunihiro
2Nakatsuka AAtsuhiro
3Nakamura TTomoki
4Fujimori MMasashi
5Yamanaka TTakashi
6Hagi TTomohito
7Matsuyama YYumi
8Iino TTakahiro
9Hasegawa MMasahiro

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CryosurgeryMajor topic
Bone NeoplasmsMajor topic
Soft Tissue NeoplasmsMajor topic
Neoplasm Recurrence, LocalMajor topic
Humans
Male
Female
Aged
Middle Aged
Adult
Aged, 80 and over
Progression-Free Survival
Young Adult

Source PubMed

Download CSV of topics

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42645393Interventional Radiology in the Treatment of Musculoskeletal Tumours.Curr Oncol2026https://conductscience.org/library/papers/42645393PubMed
40358802Percutaneous cryoablation in the management of spinal metastases: a comprehensive systematic review and meta-analysis.J Neurooncol2025https://conductscience.org/library/papers/40358802PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD68968PubTator's text mininghttps://conductscience.org/library/genes/968NCBI Gene
FCGR3A2214PubTator's text mininghttps://conductscience.org/library/genes/2214NCBI Gene
MSR14481PubTator's text mininghttps://conductscience.org/library/genes/4481NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39626907

GET https://conductscience.org/api/papers/v1/39626907/authors